Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis.
Laryngoscope. 2024 Apr 18. doi: 10.1002/lary.31438. Online ahead of print.
Laryngoscope. 2024.
PMID: 38634358
Patient perspectives on chronic rhinosinusitis in cystic fibrosis: Symptom prioritization in the era of highly effective modulator therapy.
Liu CM, Han EJ, Fischer JL, Mace JC, Mattos JL, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Eshaghian PH, Getz AE, Hwang PH, Khanwalkar A, Kimple AJ, Lee JT, Li DA, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Turner GA, Wang MB, Taylor-Cousar JL, Saavedra MT, Beswick DM.
Liu CM, et al. Among authors: eshaghian ph.
Int Forum Allergy Rhinol. 2024 Feb 11. doi: 10.1002/alr.23332. Online ahead of print.
Int Forum Allergy Rhinol. 2024.
PMID: 38343143
Item in Clipboard
Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy.
Miller JE, Taylor-Cousar JL, Overdevest JB, Khatiwada A, Mace JC, Alt JA, Bodner TE, Chowdhury NI, DiMango EA, Eshaghian PH, Getz AE, Gudis DA, Han EJ, Hwang PH, Keating CL, Khanwalkar A, Kimple AJ, Lee JT, Li D, Markarian K, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Tervo JP, Turner GA, Wang MB, Saavedra MT, Beswick DM.
Miller JE, et al. Among authors: eshaghian ph.
Int Forum Allergy Rhinol. 2024 Jun;14(6):1079-1087. doi: 10.1002/alr.23312. Epub 2023 Dec 25.
Int Forum Allergy Rhinol. 2024.
PMID: 38145393
Item in Clipboard
Preliminary evidence for sustained efficacy of CFTR modulator therapy with concomitant rifabutin administration.
Hong E, Parsons SM, Sass L, Epstein C, Chan L, Brown C, Eshaghian PH, Beringer PM.
Hong E, et al. Among authors: eshaghian ph.
J Cyst Fibros. 2023 Nov 30:S1569-1993(23)01721-6. doi: 10.1016/j.jcf.2023.11.015. Online ahead of print.
J Cyst Fibros. 2023.
PMID: 38036321
Item in Clipboard
Decreases in Rhinology Care Utilization by People with Cystic Fibrosis on Highly Effective Modulator Therapy.
Han EJ, Beswick DM, Eshaghian PH, Turner GA, Lee JT, Li DA, Wang MB, Taylor-Cousar JL, Suh JD.
Han EJ, et al. Among authors: eshaghian ph.
Ann Otol Rhinol Laryngol. 2024 Mar;133(3):340-344. doi: 10.1177/00034894231211626. Epub 2023 Nov 12.
Ann Otol Rhinol Laryngol. 2024.
PMID: 37953524
Item in Clipboard
Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy.
Beswick DM, Han EJ, Mace JC, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Eshaghian PH, Getz AE, Hwang PH, Khanwalkar A, Kimple AJ, Lee JT, Li DA, Norris M, Nayak JV, Owens C, Patel Z, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Turner G, Wang MB, Taylor-Cousar JL, Saavedra M.
Beswick DM, et al. Among authors: eshaghian ph.
Int Forum Allergy Rhinol. 2024 Apr;14(4):807-818. doi: 10.1002/alr.23270. Epub 2023 Sep 19.
Int Forum Allergy Rhinol. 2024.
PMID: 37725072
Item in Clipboard
Cite
Cite